ABION Inc.

₩3,380As of Sun 8 Nov 2026, 12:00 UTC
KOSDAQ:203400Healthcare
Country South Korea
PE (Fwd) •••
TSR 10Y CAGR (12.23%)
Div yield —
ROE (87.88%)
Biological Products, Except Diagnostic Substances
Beta (5Y) 0.85
PE TTM —
TSR TTM (73.55%)
Mkt cap ₩60.91B
ROIC (28.64%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩3,833
13.39%
48.81%
Hold 0|2|4|6|8
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
73.31
69.79
74.38
75.22
13.99%
0.24%
2.63%
7.88%
Revenue₩B
5.302
5.211
5.072
5.216
1.04%
1.65%
0.55%
(0.90%)
Peers (US$44.91M)
Cap (US$)
PE
45.74M
8.277x
44.84M
19.97x
39.01M
—
Capital
TTM
5Y
10Y
Leveragex
0.106
0.106
0.119
EBIT/Intx
0.158
0.107
0.136
Own earn%
(26.05)
(51.60)
(53.60)
Sh yield%
20.23
39.83
37.62
Owners
Insiders/Inst%
9.22
49.55
Short interest%
2.14
SBC / revenue%
5.40
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
14
Op margin range%
27–38
$1 testx
0.7
Incr. ROIC%
1